EGFR gene-mutation status correlated with therapeutic decision making in lung adenocarcinoma

EGFR gene-mutation status correlated with therapeutic decision making in lung adenocarcinoma

Yaoyao Ren, Yibing Yao, Qing Ma, Diansheng Zhong Oncology Department, Tianjin Medical University General Hospital, Tianjin, People’s Republic of China Abstract: The purpose of this study was to investigate the correlation between EGFR-mutation status and treatment efficacy for advanced l...

Full description

Bibliographic Details
Main Authors:	Ren YY, Yao YB, Ma Q, Zhong DS
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-10-01
Series:	OncoTargets and Therapy
Online Access:	https://www.dovepress.com/egfr-gene-mutation-status-correlated-with-therapeutic-decision-making--peer-reviewed-article-OTT

Similar Items

EGFR Mutation Status in Uighur Lung Adenocarcinoma Patients
by: Li SHAN, et al.
Published: (2013-02-01)

EGFR and KRAS mutation coexistence in lung adenocarcinomas
by: Vitor Manuel Leitão de Sousa, et al.
Published: (2015-04-01)

Genomic and transcriptional alterations in lung adenocarcinoma in relation to EGFR and KRAS mutation status.
by: Maria Planck, et al.
Published: (2013-01-01)

Nomogram based on preoperative CT imaging predicts the EGFR mutation status in lung adenocarcinoma
by: Guojin Zhang, et al.
Published: (2021-01-01)

Predictive Role of EGFR Mutation Status on Postoperative Prognosis in Patients  with Resected Lung Adenocarcinomas
by: Hao BAI, et al.
Published: (2013-04-01)

DOK2 inhibits EGFR-mutated lung adenocarcinoma.
by: Alice H Berger, et al.
Published: (2013-01-01)

The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas.
by: Jaeyoung Cho, et al.
Published: (2016-01-01)

Detection and Analysis of EGFR and KRAS Mutation with Lung Adenocarcinoma
by: Hui ZHANG, et al.
Published: (2015-11-01)

Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma.
by: Kazuya Takamochi, et al.
Published: (2017-01-01)

KIF5B-EGFR Fusion: A Novel EGFR Mutation in Lung Adenocarcinoma
by: Xu H, et al.
Published: (2020-08-01)

The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
by: Fu-Tsai Chung, et al.
Published: (2015-01-01)

Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases
by: Liang Shi, et al.
Published: (2021-03-01)

Mutant Proteomics of Lung Adenocarcinomas Harboring Different EGFR Mutations
by: Toshihide Nishimura, et al.
Published: (2020-08-01)

The relationship between EGFR mutation and metastasis pattern in lung adenocarcinoma
by: Ismail Beypinar, et al.
Published: (2019-08-01)

CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses
by: Dongdong Mei, et al.
Published: (2018-12-01)

MET-EGFR dimerisation in lung adenocarcinoma is dependent on EGFR mutations and altered by MET kinase inhibition
by: Lee, Richard William
Published: (2017)

Correlation between high-resolution computed tomography lung nodule characteristics and EGFR mutation in lung adenocarcinomas
by: Nie Y, et al.
Published: (2019-01-01)

The relationship between TTF-1 expression and EGFR mutations in lung adenocarcinomas.
by: Wan Shanzhi, et al.
Published: (2014-01-01)

ALK and ROS1 concurrent with EGFR mutation in patients with lung adenocarcinoma
by: Mao Y, et al.
Published: (2017-07-01)

EGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma
by: Roberto Chalela, et al.
Published: (2019-04-01)

Relationship between EGFR Mutations and Pathological Classification and  Specimen of Lung Adenocarcinoma
by: Lifei KANG, et al.
Published: (2017-06-01)

EGFR-Mutated Breast Metastasis of Lung Adenocarcinoma: A Case Report
by: Eric Dansin, et al.
Published: (2015-03-01)

Relationship between EGFR expression, copy number and mutation in lung adenocarcinomas
by: Wu Shafei, et al.
Published: (2010-07-01)

Polymer nanofiber-based microchips for EGFR mutation analysis of circulating tumor cells in lung adenocarcinoma
by: Jiang WT, et al.
Published: (2018-03-01)

Deep CNN Model Using CT Radiomics Feature Mapping Recognizes EGFR Gene Mutation Status of Lung Adenocarcinoma
by: Baihua Zhang, et al.
Published: (2021-02-01)

Histologic Transformation in EGFR-Mutant Lung Adenocarcinomas: Mechanisms and Therapeutic Implications
by: Ranjan Pathak, et al.
Published: (2021-09-01)

Specific expression of MUC21 in micropapillary elements of lung adenocarcinomas - Implications for the progression of EGFR-mutated lung adenocarcinomas.
by: Mai Matsumura, et al.
Published: (2019-01-01)

Relationship between EGFR mutation and computed tomography characteristics of the lung in patients with lung adenocarcinoma
by: Xiaowei Qiu, et al.
Published: (2019-02-01)

Impact of EGFR mutation detection methods on the efficacy of erlotinib in patients with advanced EGFR-wild type lung adenocarcinoma.
by: Jeng-Sen Tseng, et al.
Published: (2014-01-01)

Risk stratification for lung adenocarcinoma on EGFR and TP53 mutation status, chemotherapy, and PD‐L1 immunotherapy
by: Chih‐Hsun Wu, et al.
Published: (2019-10-01)

Model for predicting EGFR mutation status in lung cancer
by: Lam Nguyen Ho, et al.
Published: (2019-12-01)

Correlation between EGFR mutation status and F18‐fluorodeoxyglucose positron emission tomography‐computed tomography image features in lung adenocarcinoma
by: Lei Zhu, et al.
Published: (2019-04-01)

Erlotinib in combined therapy of common lung adenocarcinoma in the presence of EGFR gene mutation
by: S. V. Orlov, et al.
Published: (2019-06-01)

Immunogenicity of Del19 EGFR mutations in Chinese patients affected by lung adenocarcinoma
by: Deng Pan, et al.
Published: (2019-11-01)

Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma.
by: Federica Zito Marino, et al.
Published: (2015-01-01)

Radiomics Signature as a Predictive Factor for EGFR Mutations in Advanced Lung Adenocarcinoma
by: Duo Hong, et al.
Published: (2020-01-01)

Conventional transbronchial needle aspiration is promising for identifying EGFR mutations in lung adenocarcinoma
by: Li‐Han Hsu, et al.
Published: (2019-04-01)

Lung Adenocarcinoma with Pulmonary Miliary Metastases and Complex Somatic Heterozygous EGFR Mutation
by: Alexandre Schaller, et al.
Published: (2014-11-01)

Detected EGFR mutation in cerebrospinal fluid of lung adenocarcinoma patients with meningeal metastasis
by: Rong Jiang, et al.
Published: (2016-01-01)

Differences in Immunological Landscape between EGFR-Mutated and Wild-Type Lung Adenocarcinoma
by: Jia-Wei Luo, et al.
Published: (2021-01-01)